Galmed Pharmaceuticals Ltd
NASDAQ:GLMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD
|
IL |
|
Hirakawa Hewtech Corp
TSE:5821
|
JP |
|
Beta Systems Software AG
F:BSS
|
DE |
|
A
|
Arcellx Inc
NASDAQ:ACLX
|
US |
|
Sanwei Holding Group Co Ltd
SSE:603033
|
CN |
|
Shenzhen Kstar Science & Technology Co Ltd
SZSE:002518
|
CN |
|
A
|
Amulaire Thermal Technology Inc
TWSE:2241
|
TW |
|
Wonder Electricals Ltd
NSE:WEL
|
IN |
|
Evergrande Property Services Group Ltd
HKEX:6666
|
CN |
Galmed Pharmaceuticals Ltd
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
